Enrofloxacin is a fluoroquinolone antibiotic with bactericidal activity against many Gram-negative bacteria, against Gram-positive bacteria and Mycoplasma spp. It inhibits DNA and mRNA synthesis, resulting in a rapid, drug concentration-dependent killing of pathogenic bacteria. Enrofloxacin is generally well absorbed, is widely distributed to all tissues and eliminated rapidly via both urine and faeces.